117 related articles for article (PubMed ID: 30763959)
1. [Ocular Phenotype and Complications in Patients with Tuberous Sclerosis Complex (TSC)].
Zweipfenning F; Toelle SP; Gerth-Kahlert C
Klin Monbl Augenheilkd; 2019 Apr; 236(4):462-468. PubMed ID: 30763959
[TBL] [Abstract][Full Text] [Related]
2. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
[TBL] [Abstract][Full Text] [Related]
3. Aggressive retinal astrocytomas in four patients with tuberous sclerosis complex.
Shields JA; Eagle RC; Shields CL; Marr BP
Trans Am Ophthalmol Soc; 2004; 102():139-47; discussion 147-8. PubMed ID: 15747752
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmic manifestations of tuberous sclerosis: a population based study.
Rowley SA; O'Callaghan FJ; Osborne JP
Br J Ophthalmol; 2001 Apr; 85(4):420-3. PubMed ID: 11264130
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic manifestations in children with tuberous sclerosis complex.
Öhnell HM; Kjellström U; Eklund E; Pearsson K; Bekassy Z; Gränse L
Acta Ophthalmol; 2024 Jun; 102(4):421-427. PubMed ID: 37991117
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S
Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
[TBL] [Abstract][Full Text] [Related]
7. Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.
Tsai JD; Wei CC; Tsao TF; Hsiao YP; Tsai HJ; Yang SH; Tsai ML; Sheu JN
Childs Nerv Syst; 2016 Jan; 32(1):89-95. PubMed ID: 26552385
[TBL] [Abstract][Full Text] [Related]
8. Juvenile cataract in association with tuberous sclerosis complex.
Geffrey AL; Geenen KR; Abati E; Greenstein SH; VanderVeen DK; Levy RL; Davidson SL; McGarrey MP; Thiele EA; Aronow ME
Ophthalmic Genet; 2020 Aug; 41(4):345-349. PubMed ID: 32340510
[TBL] [Abstract][Full Text] [Related]
9. Ophthalmic manifestations of tuberous sclerosis: a review.
Hodgson N; Kinori M; Goldbaum MH; Robbins SL
Clin Exp Ophthalmol; 2017 Jan; 45(1):81-86. PubMed ID: 27447981
[TBL] [Abstract][Full Text] [Related]
10. Subependymal giant cell tumors in tuberous sclerosis complex.
Goh S; Butler W; Thiele EA
Neurology; 2004 Oct; 63(8):1457-61. PubMed ID: 15505165
[TBL] [Abstract][Full Text] [Related]
11. Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2.
Peron A; Vignoli A; Briola F; Morenghi E; Tansini L; Alfano RM; Bulfamante G; Terraneo S; Ghelma F; Banderali G; Viskochil DH; Carey JC; Canevini MP;
Eur J Med Genet; 2018 Jul; 61(7):403-410. PubMed ID: 29432982
[TBL] [Abstract][Full Text] [Related]
12. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
[TBL] [Abstract][Full Text] [Related]
13. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
[TBL] [Abstract][Full Text] [Related]
14. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.
Jóźwiak S; Nabbout R; Curatolo P;
Eur J Paediatr Neurol; 2013 Jul; 17(4):348-52. PubMed ID: 23391693
[TBL] [Abstract][Full Text] [Related]
15. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U
J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309
[TBL] [Abstract][Full Text] [Related]
16. Analysis of genotypes and phenotypes in Chinese children with tuberous sclerosis complex.
Bai D; Zhao J; Li L; Gao J; Wang X
Sci China Life Sci; 2017 Jul; 60(7):763-771. PubMed ID: 28623545
[TBL] [Abstract][Full Text] [Related]
17. Retinal astrocytoma regression in tuberous sclerosis patients treated with everolimus.
Zipori AB; Tehrani NN; Ali A
J AAPOS; 2018 Feb; 22(1):76-79. PubMed ID: 29277498
[TBL] [Abstract][Full Text] [Related]
18. Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective.
Berhouma M
World J Pediatr; 2010 May; 6(2):103-10. PubMed ID: 20490765
[TBL] [Abstract][Full Text] [Related]
19. [The fundus autofluorescence of retinal astrocytic hamartomas in tuberous sclerosis complex].
Zhang CX; Zhang ZQ; Xu KF; Long Q; Yang ZK; Dai RP; Du H; Li DH
Zhonghua Yan Ke Za Zhi; 2020 Mar; 56(3):211-216. PubMed ID: 32187950
[No Abstract] [Full Text] [Related]
20. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
Tomoto K; Fujimoto A; Inenaga C; Okanishi T; Imai S; Ogai M; Fukunaga A; Nakamura H; Sato K; Obana A; Masui T; Arai Y; Enoki H
BMC Neurol; 2021 Mar; 21(1):139. PubMed ID: 33784976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
